Semisynthetic modifications of antitubercular lanostane triterpenoids from Ganoderma
Authors:
- 12 May 2021
- journal article
- research article
- Published by Springer Nature in The Journal of Antibiotics
- Vol. 74 (7) , 435-442
Abstract
Antitubercular lanostane triterpenoids isolated from mycelial cultures of the basidiomycete Ganoderma australe were structurally modified by semisynthesis. One of the synthetic compounds, named GA003 (9), showed more potent activity against Mycobacterium tuberculosis H37Ra than the lead natural lanostane (1). GA003 was also significantly active against the virulent strain (H37Rv) as well as extensively drug-resistant tuberculosis strains.Keywords
Funding Information
- Thailand Research Fund (DBG6280008)
This publication has 14 references indexed in Scilit:
- Antitubercular Lanostane Triterpenes from Cultures of the Basidiomycete Ganoderma sp. BCC 16642Journal of Natural Products, 2015
- Secondary metabolites from GanodermaPhytochemistry, 2015
- A Comprehensive Review of the Structure Elucidation and Biological Activity of Triterpenoids from Ganoderma spp.Molecules, 2014
- Lanostane triterpenes from cultures of the Basidiomycete Ganoderma orbiforme BCC 22324Phytochemistry, 2013
- A new ganoderic acid from Ganoderma lucidum mycelia and its stabilityFitoterapia, 2013
- Ganoderma – A therapeutic fungal biofactoryPhytochemistry, 2006
- Improved Green Fluorescent Protein Reporter Gene-BasedMicroplate Screening for Antituberculosis Compounds by Utilizing anAcetamidasePromoterAntimicrobial Agents and Chemotherapy, 2003
- Triterpenes in Ganoderma lucidumPhytochemistry, 1988
- Triterpenes from Ganoderma lucidumPhytochemistry, 1988
- Two New Triterpenes of the Fungus Ganoderma lucidumJournal of Natural Products, 1987